The European Association of Nuclear Medicine (EANM) has temporarily suspended the Russian Society of Nuclear Medicine (RSNM) as a national society within the association.
In her president's letter sent to EANM members on 8 April, Dr. Jolanta Kunikowska, PhD, said that the EANM is showing solidarity toward Ukraine and condemns the ongoing war. She wrote that the war threatens peace and stability within Europe, as well as the safety and security of nuclear facilities.
"Even though the situation is difficult and unpredictable, we will be continuing with our duties," added Kunikowska, who is an assistant professor at the Nuclear Medicine Department, Medical University in Warsaw, Poland.
She continued by elaborating on the association's priorities, which include the EANM's involvement in European Union (EU)-related initiatives and projects. A new EANM Policy & Regulatory Affairs Committee will work with the association's board on strategy and advice regarding EU-related matters.
The association also reached agreement on a majority of questions with the European Association of Urology on the role of prostate-specific membrane antigen PET/CT in radioligand therapy (Lu-177 PSMA) in prostate cancer.
The letter also announced the date for the EANM Focus Meeting 5 on "Molecular Imaging and Theranostics in Prostate Cancer -- the Future Begins Today," which will be held on 2-4 February 2023 in Seville, Spain.